Location History:
- Bernaardsville, NJ (US) (2021)
- Bernardsville, NJ (US) (2014 - 2023)
Company Filing History:
Years Active: 2014-2023
Title: Clive Arthur Arculus-Meanwell: Innovator in Ischemic Event Prevention
Introduction
Clive Arthur Arculus-Meanwell is a notable inventor based in Bernardsville, NJ (US). He has made significant contributions to the field of medicine, particularly in the prevention and treatment of ischemic events. With a total of 8 patents to his name, his work has the potential to impact patient care significantly.
Latest Patents
Arculus-Meanwell's latest patents focus on methods for treating, reducing the incidence of, and preventing ischemic events in patients undergoing percutaneous coronary intervention (PCI). One of his key inventions involves a pharmaceutical composition comprising cangrelor, which may be administered alongside additional therapeutic agents such as bivalirudin or a P2Y inhibitor. His patents also detail methods for preparing these pharmaceutical compositions, emphasizing the importance of cangrelor in preventing serious complications like stent thrombosis and myocardial infarction.
Career Highlights
Throughout his career, Arculus-Meanwell has worked with prominent companies in the pharmaceutical industry, including Chiesi Farmaceutici S.p.a. and The Medicines Company. His expertise in developing innovative treatments has positioned him as a valuable asset in the medical field.
Collaborations
Arculus-Meanwell has collaborated with notable professionals such as Simona Skerjanec and Jayne Prats, contributing to the advancement of medical treatments and research.
Conclusion
Clive Arthur Arculus-Meanwell's innovative work in the prevention and treatment of ischemic events showcases his dedication to improving patient outcomes. His patents and collaborations reflect a commitment to advancing medical science and enhancing therapeutic options for patients.